Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | true | Inferred relationship | Some | ||
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator unit | hour | true | Inferred relationship | Some | 1 | |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Buprenorphine-containing product in transdermal dose form | false | Inferred relationship | Some | ||
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance (attribute) | Buprenorphine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | har täljarvärde för koncentrationsstyrka | 70 | false | Inferred relationship | Some | 1 | |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | Buprenorphine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Product containing only buprenorphine in transdermal dose form (medicinal product form) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets